Micromedex RED BOOK: Drug Pricing & Data Guide

Micromedex RED BOOK is an industry-standard reference database providing pharmaceutical pricing benchmarks, product descriptions, and packaging data across the US commercial drug supply. Established in 1896 and trusted for over 50 years, RED BOOK indexes virtually every prescription drug, over-the-counter (OTC) formula, compounding chemical, medical device, and nutritional product approved by the US Food and Drug Administration (FDA) for commercial distribution.

Healthcare systems, pharmacies, pharmacy benefit managers (PBMs), health plans, and researchers rely on RED BOOK to verify acquisition benchmarks, calculate reimbursement, track National Drug Codes (NDCs), and manage formularies. This guide outlines how Micromedex RED BOOK operates, its core pricing benchmarks, query workflows, platform capabilities, and alternative compendia.

What It Is

Micromedex RED BOOK is a specialized pharmaceutical pricing and product identification database published by Merative. In clinical and academic environments, RED BOOK should not be confused with the American Academy of Pediatrics (AAP) Red Book on infectious diseases or the Federal Reserve’s Red Book on economic conditions. In pharmacy administration and health economics, RED BOOK refers specifically to the drug pricing catalog founded in 1896 by the Druggists Circular and now delivered within the Micromedex suite.

The platform aggregates manufacturer prices, statutory baselines, packaging details, and regulatory identifiers into a standardized relational database. It supplies an auditable baseline for provider-payer contracts, reimbursement formulas, inventory valuation, and health services research.

Access requires an institutional subscription. Authorized users sign in through their hospital intranet, university library proxy, or via the Merative Micromedex portal at micromedexsolutions.com by opening the RED BOOK module tab on the main dashboard.

Who Runs It and What It Covers

Micromedex RED BOOK is maintained by Merative, formerly part of IBM Watson Health and Truven Health Analytics. Editorial staff track daily manufacturer price notices, FDA filings, and reimbursement updates to maintain an exhaustive commercial record.

The compendium encompasses virtually all products assigned an NDC, Universal Product Code (UPC), or Health Related Item (HRI) code. Covered product segments include:

Prescription Drugs: Brand-name innovator products, multi-source generics, and authorized generics.
Over-the-Counter Products: Packaged non-prescription medications, analgesics, and topical preparations.
Compounding Chemicals: Bulk active pharmaceutical ingredients (APIs) and excipients.
Medical Devices and Supplies: Wound dressings, administration sets, and diagnostic items.
Nutritional Formulas: Enteral formulas, infant nutrition, and dietary supplements.
Biologicals and Vaccines: Storage requirements and pricing for vaccines and cellular therapies.

RED BOOK indexes eight distinct industry pricing benchmarks and administrative coding metrics:

Average Wholesale Price (AWP): The primary historical benchmark for pharmacy reimbursement. Under the Merative RED BOOK AWP Policy, if a manufacturer provides an AWP, RED BOOK publishes it; if omitted, RED BOOK derives it using the standard markup formula documented in the 236-page RED BOOK AWP Markup Report.
Wholesale Acquisition Cost (WAC): The manufacturer’s list price for direct sales to wholesalers, excluding rebates or discounts.
Direct Price (DIR): The catalog price charged by a manufacturer when selling directly to dispensing accounts.
National Average Drug Acquisition Cost (NADAC): CMS survey benchmark reflecting actual community pharmacy invoice costs.
Maximum Fair Price (MFP): Federally negotiated ceiling prices for select Medicare drugs under the Inflation Reduction Act.
Suggested Retail Price (SRP): The manufacturer’s suggested consumer price for OTC items and retail supplies.
Federal Upper Limit (FUL): The statutory reimbursement ceiling set by CMS for multi-source generic drugs under Medicaid.
HCPCS J-Codes: Medical billing codes linking physician-administered injectables to claims.

Product records incorporate regulatory attributes from the FDA NDC Directory and cross-reference public datasets from openFDA for bioequivalence ratings, active ingredient strengths, and dosage forms.

How to Search or Use It

Documented in official guides from the Merative Micromedex Training Center, users query RED BOOK through six structured steps:

Access the RED BOOK Interface: Log into the Micromedex portal with institutional credentials and select the “RED BOOK” module tab.
Select the Search Method: Choose among Product Name Search (brand or generic name), Active Ingredient Search (single-entity and combination products), NDC / HRI / UPC Search (10- or 11-digit NDC, 12-digit UPC, or 10-digit HRI code), or Manufacturer Search (reviewing corporate catalogs).
Filter Search Results: Narrow results by marketing status—separating active products from deactivated records—and toggle repackagers to isolate original manufacturer packaging from secondary relabelers.
Inspect Product Details: Select an item to view package size, quantity, unit price, package price (AWP, WAC, DIR), active ingredients, and update effective dates.
Review Price Change History: Open the Price Change view to track historical price revisions, effective dates, and percentage shifts.
Manage Cohorts with Custom List Manager: Add tracked items to the Custom List Manager to save product cohorts and export data to Microsoft Excel for financial modeling, pairing with Merative MarketScan Research Databases for health economics, or cross-referencing clinical evidence in DynaMedex.

Strengths and Limits

Evaluating RED BOOK requires understanding its practical strengths and administrative constraints:

Strengths:

Exhaustive US Coverage: Encompasses virtually every FDA-approved drug, OTC item, compounding chemical, and medical supply in US commerce.
Multi-Benchmark Pricing: Provides simultaneous access to AWP, WAC, DIR, NADAC, and FUL metrics.
Dual Delivery Formats: Offers interactive web lookup alongside 43-page RED BOOK Product Guide flat-file data feeds for EHR and PBM integration.
Longitudinal Price Archive: Maintains decades of historical pricing changes essential for health economics and claims audits.

Limits:

List vs. Net Transaction Prices: AWP and WAC reflect list figures that do not incorporate manufacturer rebates, 340B discounts, or commercial payer discounts.
US Geographic Focus: Confined to US FDA-regulated drugs and reimbursement systems; international drug pricing is omitted.
Subscription Paywall: Proprietary commercial licensing is required; no public API is offered.
Focused Scope: Detailed pharmacology monographs, drug interactions, and toxicology require separate Micromedex modules such as DRUGDEX or Poisindex.

Alternatives

Organizations choose between commercial compendia and open regulatory datasets based on operational needs and integration requirements:

Platform / Tool	Publisher	Key Pricing & Coding Metrics	Delivery Mode	Primary Use Case
Micromedex RED BOOK	Merative	AWP, WAC, DIR, NADAC, MFP, FUL, J-Codes	Web portal & flat-file feeds	Hospital formulary management, PBM adjudication, health economics
Medi-Span Price Rx	Wolters Kluwer	AWP, WAC, Direct Price, GPI codes	Online search & data feeds	Retail pharmacy management systems, PBM claims processing
FDB MedKnowledge	First Databank	AWP, WAC, Direct Price, HICL codes	EHR modules & data files	Inpatient order entry, clinical drug screening, dispensing
ProspectoRx / Clinical Pharmacology	Elsevier	AWP, WAC, Direct Price, bioequivalence	Web portal & API integration	Pharmacy education, drug information centers, formulary review
CMS NADAC & FUL Files	Centers for Medicare & Medicaid Services	Surveyed retail acquisition cost, Medicaid FUL	Public CSV/JSON downloads	Public policy research, state Medicaid reimbursement benchmarks
FDA Orange Book & NDC Directory	US Food and Drug Administration	Therapeutic equivalence codes, active NDCs (no pricing)	Public web search & text files	Generic substitution verification, patent review, regulatory audit

While health systems license commercial compendia for operational claims automation, academic researchers often combine RED BOOK with open CMS datasets for transparent health services research.

FAQ

What is the difference between AWP and WAC in Micromedex RED BOOK?

Wholesale Acquisition Cost (WAC) is the manufacturer’s published catalog list price for sales to wholesalers, excluding rebates. Average Wholesale Price (AWP) is a benchmark traditionally calculated at a standard markup (typically 20% to 25%) above WAC, used by payers for prescription reimbursement formulas.

Does Micromedex RED BOOK include over-the-counter and compounding items?

Yes. Along with prescription brand-name and generic drugs, RED BOOK indexes prices, packaging sizes, and manufacturer data for over-the-counter (OTC) medications, active compounding bulk chemicals, medical devices, and specialized nutritional formulas.

How does Merative calculate derived AWPs under the RED BOOK AWP Policy?

When a manufacturer omits an official AWP, Merative applies the published RED BOOK AWP Policy. The system calculates a derived AWP by applying a standardized markup percentage to the manufacturer’s verified WAC or Direct Price.

What delivery formats are available for enterprise IT integration?

Merative distributes RED BOOK via two formats: an interactive web interface within the Micromedex portal for ad-hoc inquiries, and 43-page RED BOOK Product Guide flat-file database feeds for hospital EHR and PBM integration.

How does RED BOOK differ from the FDA Orange Book?

The FDA Orange Book evaluates therapeutic equivalence and patent exclusivity without drug pricing. RED BOOK incorporates FDA equivalence ratings while adding comprehensive multi-source pricing benchmarks (AWP, WAC, NADAC, DIR) and packaging data.

Where can authorized users find the RED BOOK sign-in?

Institutional users access RED BOOK through their hospital or university library single sign-on (SSO) gateway, or directly at micromedexsolutions.com by entering authorized credentials and opening the “RED BOOK” module tab on the main dashboard.

Sources

Merative Micromedex. “Drug Pricing from Micromedex RED BOOK.” Official product overview. https://www.micromedex.com/products/micromedex-redbook. Checked 2026-11-09.
Merative Micromedex Training Center. “Micromedex RED BOOK® Tutorial, AWP Policy, and Product Guides.” Educational scenario tutorial and technical documentation. https://www.merative.com/micromedex-training-center/red-book. Checked 2026-11-09.
Merative Clinical Decision Support. “Micromedex RED BOOK Datasheet & Flexible Access Options.” Enterprise deployment overview. https://www.merative.com/documents/micromedex-red-book. Checked 2026-11-09.
University of Health Sciences and Pharmacy in St. Louis (UHSP). “Red Book via Micromedex.” Library drug information guide. https://uhsp.libguides.com/az/red-book-via-micromedex. Checked 2026-11-09.
US Food and Drug Administration (FDA). “National Drug Code Directory Database and Guidance.” https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory. Checked 2026-11-09.